TABLE 4.
Major adverse events within 30 days.
| Group-n (%) | Device-related complications | Procedural complications |
| Pericardial effusion | 6 (8.8) | 1 (1.5) |
| Cardiac tamponade | 0 (0.0) | 0 (0.0) |
| Pleural effusion | 0 (0.0) | 0 (0.0) |
| Transient idioventricular rhythm | 19 (27.9) | 0 (0.0) |
| VT (> 120 bpm) | 0 (0.0) | 0 (0.0) |
| CLBBB | 1 (1.5) | 0 (0.0) |
| CRBBB | 6 (8.8) | 0 (0.0) |
| AVB | 0 (0.0) | 0 (0.0) |
| CHB | 0 (0.0) | 0 (0.0) |
| VF | 1 (1.5) | 0 (0.0) |
| Hypotension | 1 (1.5) | 0 (0.0) |
| Ventricular septal pseudoaneurysm | 0 (0.0) | 0 (0.0) |
| Ventricular septal perforation | 0 (0.0) | 0 (0.0) |
| Infection | 0 (0.0) | 0 (0.0) |
| Stroke | 0 (0.0) | 0 (0.0) |
| Recovery after SCD | 1 (1.5) | 0 (0.0) |
| Death | 0 (0.0) | 0 (0.0) |
AVB, atrial ventricular block; CHB, complete heart block; CLBBB, complete left bundle branch block; CRBBB, complete right bundle branch block; SCD, sudden cardiac death; VF, ventricular fibrillation; VT, ventricular tachycardia.